BioSpace News Archive

Society of Vascular and Interventional Neurology The Society of Vascular and Interventional Neurology releases the Advanced Stroke Emergency Support EMS training course.

Non-profit drug developer, TB Alliance, and pharmaceutical company, Mylan N.V. (NASDAQ: MYL), today announced a global collaboration to make the experimental drug pretomanid accessible for use in two investigational drug regimens for pulmonary tuberculosis (TB).

Indalo Therapeutics, a biopharmaceutical company discovering and developing integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF), today announced the first healthy volunteer has been dosed in a Phase 1 clinical trial of the company’s lead drug candidate IDL-2965.

Alafair Biosciences, Inc., a commercial-stage medical device company, announced that it raised over $7.2 million in an oversubscribed Series B/B-1 financing to fund its next phase of growth.

The Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal is proud to contribute to the first edition of EFFERVESCENCE, a major event in the Life Sciences and Health Technologies sector, driven by Montréal InVivo and organized by a group of 14 partners, to be held on April 24 and 25 at TOHU.

It’s awards season, and the WellCare Health Plans, Inc. (NYSE: WCG) (WellCare) Legal team is celebrating being named Legal Department of the Year by the Daily Business Review in the 2019 Florida Legal Awards.

World’s 1st Door Handles that Dispense Hand Sanitizer Makes Hand Sanitizing Easy, Intuitive and Accessible

Medison Biotech (1995) Ltd. (“Medison”), which together with its affiliates owns more than 10.4 million shares or 7.3% of Knight Therapeutics, Inc. (TSX:GUD) (“Knight” or the “Company”), today made its case for urgent change, improved governance and a promising future at the Company in a detailed presentation to shareholders.

Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today launched three new sexually transmitted disease (STD) laboratory test packages that individuals can purchase online for some of the most prevalent STDs in the United States.

Seven-Unit Core Positioned to Push Most Promising Drug Candidates Directly to Patient Trial